ANALYSIS ON THE THERAPEUTIC POTENTIALS OF MADHUKADI CHURNA IN ASRIGDAR W.S.R TO DUB.
Article pdf download
Publication Certificate

Keywords

Asrigdar, Madhukadi churna, DUB, Herbomineral drug

How to Cite

acharekar, gandhali. (2020). ANALYSIS ON THE THERAPEUTIC POTENTIALS OF MADHUKADI CHURNA IN ASRIGDAR W.S.R TO DUB. National Journal of Research in Ayurved Science, 8(06). Retrieved from https://ayurlog.com/index.php/ayurlog/article/view/724

Abstract

Asrigdar is a gynaecological condition defined as excessive bleeding during menstruation. Acharya Charak has described this condition due to vitiation of vata & pitta dosha along with rakta dosha. According to modern science, dysfunctional uterine bleeding (DUB) is an irregular, excessive uterine bleeding without any organic cause in the uterus which correlates with the Asrigdar vyadhi mentioned in Ayurveda literature. This condition affects women’s health both medically & socially. Acharya Sushrut says if remain untreated Asrigdar can lead to various complications such as Pandu (anaemia), Vatavyadhi. In the present review the drugs present in madhukadi churna were compiled, analysed and presented scientifically along with their probable mode of action in the management of Asrigdar based on various reported research work. Madhukadi churna is a Rakta –pitta shamak, rakta sangrahaniya combination and also balances vata dosha and kapha dosha. It is a rakta sangrahaniya kalpa due to its tikta kashaya, madhur rasa and sheet virya. Madhukadi churna has potent yonisankochakar (astringent effect on uterine vessels) and raktastrav rodhak (Haemostatic) properties.  The drugs in madhukadi churna are proven for their phytoestrogenic action, astringent effect, haemostatic action, muscle relaxant activity, anti-thrombin activity, balances FSH, LH hormones thereby useful for treating  Asrigdar (DUB). The present review work reports that madhukadi churna can be used for treating Asrigdar.

Article pdf download
Publication Certificate
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.